No link to higher MG risks found with inactivated COVID-19 vaccine
The use of an inactivated vaccine against SARS-CoV-2, the virus that causes COVID-19, is not linked to an increased risk…
Articles by Patricia Inacio, PhD
Thymectomy Raises Autoimmune Risk in Some MG Patients
The risk of developing another autoimmune disease, especially rheumatoid arthritis, increased in people with myasthenia gravis (MG) after surgery…
Many gMG Patients in US Show ‘Chronic’ Reliance on IVIG Therapy
Over 40% of adults with generalized myasthenia gravis (gMG) in the U.S. who began off-label treatment with intravenous…
Telitacicept Shows Signs of Efficacy, Safety in Phase 2 Trial in MG Adults
Nearly six months of treatment with telitacicept (RC18), an anti-inflammatory developed by RemeGen, safely lessened disease severity in adults…
FDA Clears Proof-of-concept Study for CNP-106 Immune Therapy
Cour Pharmaceuticals is launching a Phase 1b/2a proof-of-concept study to evaluate the safety and preliminary effectiveness of its investigational…
Immunosuppressive Therapy Tied to More COVID-19 Hospitalization Risk
People with myasthenia gravis (MG) who are receiving immunosuppressive therapy are more likely to be hospitalized for a COVID-19…
Long-term Immunotherapy for MG Linked to Anemia in Female Patients
Long-term immunotherapy may cause anemia in female patients with myasthenia gravis (MG), according to a Japanese study that found…
2 Infusion Centers for gMG Patients, Assisted by Nurses, Open in Ohio
Virtis Health announced that it will open two ambulatory centers in Ohio — one in Columbus and the other…
Onset of MG Following Sinopharm’s COVID-19 Vaccine Reported
Researchers in Iran reported the first case of myasthenia gravis (MG) following a Sinopharm vaccination against SARS-CoV-2, the virus…
3 Cases of MG Possibly Caused by COVID-19 Vaccination: Report
Researchers in Italy have reported three cases of myasthenia gravis (MG) they say may possibly have been caused by…